Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

49 recalls, newest first

Class III · Low risk

Amlodipine Besylate Tablet

PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.

Terminated Particulate / foreign matter Ascend Laboratories LLC NDC 67877-199-10 D-1134-2017
Class II · Moderate risk

ATENOLOL Tablets

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Terminated Particulate / foreign matter Legacy Pharmaceutical Packaging LLC NDC 68645-493-54 D-0606-2017
Class II · Moderate risk

ATENOLOL Tablets

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Terminated Particulate / foreign matter Zydus Pharmaceuticals USA Inc NDC 68382-023-01 D-0605-2017
Class II · Moderate risk

Mirtazapine Tablets

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Terminated Particulate / foreign matter Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-088-20 D-0493-2017
Class I · High risk

Vancomycin Hydrochloride for Injection

Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.

Terminated Particulate / foreign matter Hospira Inc., A Pfizer Company NDC 0409-6510-01 D-0638-2017

Recalls by year